Line 22: | Line 22: | ||
<tr> | <tr> | ||
<td align="center"; width="50%"> | <td align="center"; width="50%"> | ||
− | < | + | <p class="numbertext">1 / 6</p> |
− | <img src="https://static.igem.org/mediawiki/2018/thumb/6/6c/T--Duke--Daniel.jpg/1200px-T--Duke--Daniel.jpg" style="width:270px;height:300px;"></td> | + | <img src="https://static.igem.org/mediawiki/2018/thumb/6/6c/T--Duke--Daniel.jpg/1200px-T--Duke--Daniel.jpg" style="width:270px;height:300px;"> |
+ | </td> | ||
<td align="center"; width="50%"><h4>Daniel Getman</h4> | <td align="center"; width="50%"><h4>Daniel Getman</h4> | ||
<p><br>Daniel Getman is a senior at Duke University studying Neuroscience. He joined the Duke iGEM team and Lynch Lab in fall 2017. His hobbies include archery, hiking, and spending time with friends. After graduating he plans to taking a gap year to continue his research on miraculin and afterwards attend medical school.</p> | <p><br>Daniel Getman is a senior at Duke University studying Neuroscience. He joined the Duke iGEM team and Lynch Lab in fall 2017. His hobbies include archery, hiking, and spending time with friends. After graduating he plans to taking a gap year to continue his research on miraculin and afterwards attend medical school.</p> |
Revision as of 19:50, 16 October 2018